GlobalData on MSN19d
Semaglutide shortage ends as FDA sets deadline for compoundersWith Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback